JP2011525361A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525361A5
JP2011525361A5 JP2011515164A JP2011515164A JP2011525361A5 JP 2011525361 A5 JP2011525361 A5 JP 2011525361A5 JP 2011515164 A JP2011515164 A JP 2011515164A JP 2011515164 A JP2011515164 A JP 2011515164A JP 2011525361 A5 JP2011525361 A5 JP 2011525361A5
Authority
JP
Japan
Prior art keywords
spqqgdh
seq
wild type
sequence
acinetobacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011515164A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525361A (ja
Filing date
Publication date
Priority claimed from DE102008030435A external-priority patent/DE102008030435A1/de
Application filed filed Critical
Publication of JP2011525361A publication Critical patent/JP2011525361A/ja
Publication of JP2011525361A5 publication Critical patent/JP2011525361A5/ja
Pending legal-status Critical Current

Links

JP2011515164A 2008-06-26 2009-06-17 向上した基質特異性を有するｐｑｑ−依存的グルコースデヒドロゲナーゼの新規変異体 Pending JP2011525361A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008030435A DE102008030435A1 (de) 2008-06-26 2008-06-26 Neuartige Varianten PQQ-abhängiger Glukosehydrogenase mit verbesserter Substratspezifität
DE102008030435.2 2008-06-26
PCT/EP2009/004350 WO2009156083A1 (de) 2008-06-26 2009-06-17 Neuartige varianten pqq-abhängiger glukosedehydrogenase mit verbesserter substratspezifität

Publications (2)

Publication Number Publication Date
JP2011525361A JP2011525361A (ja) 2011-09-22
JP2011525361A5 true JP2011525361A5 (enExample) 2012-08-02

Family

ID=40972803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011515164A Pending JP2011525361A (ja) 2008-06-26 2009-06-17 向上した基質特異性を有するｐｑｑ−依存的グルコースデヒドロゲナーゼの新規変異体

Country Status (6)

Country Link
US (1) US8580547B2 (enExample)
EP (1) EP2294188A1 (enExample)
JP (1) JP2011525361A (enExample)
CN (2) CN102076846A (enExample)
DE (1) DE102008030435A1 (enExample)
WO (1) WO2009156083A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2655650B1 (en) 2010-12-20 2017-12-20 LEK Pharmaceuticals d.d. Enzymatic synthesis of active pharmaceutical ingredient and intermediates thereof
EP2465936A1 (en) 2010-12-20 2012-06-20 LEK Pharmaceuticals d.d. Enzymatic synthesis of statins and intermediates thereof
CN111073866B (zh) 2015-10-29 2024-03-19 英科隆生物技术（杭州）有限公司 PQQ-sGDH突变体、聚核苷酸及其在葡萄糖检测中的应用
CN109085269B (zh) * 2018-08-15 2021-03-09 江苏省原子医学研究所 PQQ与Lys及Arg反应行为研究的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1184472C (zh) 1999-10-05 2005-01-12 松下电器产业株式会社 葡萄糖传感器
WO2002034919A1 (en) 2000-10-27 2002-05-02 Roche Diagnostics Gmbh Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
EP1367120A3 (en) 2002-05-27 2004-06-02 Toyo Boseki Kabushiki Kaisha Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase with superior substrate specificity and stability
DE10320259A1 (de) 2003-05-07 2004-11-25 Bayer Technology Services Gmbh Neuartige Glukose Dehydrogenase und ihre Herstellung
DE602004023736D1 (de) 2003-09-08 2009-12-03 Toyo Boseki Pyrrolochinolin-chinon (pqq)-abhängige glucosedehydrogenase-modifikation mit ausgezeichneter substratspezifität
JP2007043983A (ja) * 2005-08-11 2007-02-22 Toyobo Co Ltd 基質特異性に優れた改変型ピロロキノリンキノン依存性グルコースデヒドロゲナーゼ
JP2007000020A (ja) * 2005-06-21 2007-01-11 Toyobo Co Ltd 基質特異性に優れたピロロキノリンキノン（ｐｑｑ）依存性グルコースデヒドロゲナーゼ改変体
WO2006085509A1 (ja) * 2005-02-08 2006-08-17 Toyo Boseki Kabushiki Kaisha 基質特異性に優れた改変型ピロロキノリンキノン依存性グルコースデヒドロゲナーゼ
JP2006217810A (ja) * 2005-02-08 2006-08-24 Toyobo Co Ltd 基質特異性に優れたピロロキノリンキノン（ｐｑｑ）依存性グルコースデヒドロゲナーゼ改変体

Similar Documents

Publication Publication Date Title
JP2012034696A5 (enExample)
JP2008245635A5 (enExample)
JP2010534684A5 (enExample)
WO2012101599A3 (en) Glycogen synthase kinase-3 inhibitors
WO2009108856A3 (en) Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof
WO2010035107A3 (en) Peptides and compositions for prevention of cell adhesion and methods of using same
JP2010065037A5 (enExample)
SI1935331T1 (sl) Postopek za pripravo modificiranih elektrod, elektrode pripravljene z omenjenim postopkom in encimatski biosenzorji, ki obsegajo omenjene elektrode
JP2010227108A5 (enExample)
WO2011163652A3 (en) Treatment of sanfilippo syndrome type b
FR2927619B1 (fr) Croissance de nanotubes de carbone sur substrats de carbone ou metalliques.
WO2009004315A8 (en) Isolated peptides and uses thereof
WO2010015929A3 (en) Uses of mesenchymal stem cells
WO2009013468A3 (en) Late blight resistance genes and methods
JP2009504138A5 (enExample)
WO2009120380A3 (en) Recombinant rhinovirus vectors
WO2011039519A3 (en) ACETYL LYSINE INCORPORATION WITH tRNA SYNTHETASE
JP2011525361A5 (enExample)
JP2010265269A5 (enExample)
WO2009120712A3 (en) Compositions and methods for diagnosing and treating melanoma
WO2010026219A3 (en) New tomato ethylene response factors and uses thereof
WO2008122817A3 (en) Immunogenic compositions
WO2011099000A3 (en) Pharmaceutical composition for treating the gastrointestinal tract
WO2010043973A3 (en) Biomarkers for dengue
WO2010042685A3 (en) Inhibitors of the atb(0,+) transporter and uses thereof